- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, March 19, 2021
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article by the website of the American Pharmacists Association referenced a study published in the April 2010 issue of The American Journal of Managed Care® (AJMC®) titled “Pharmacist Collaborative Management of Poorly Controlled Diabetes Mellitus: A Randomized Controlled Trial.” The study found that pharmacist management of poorly controlled diabetes resulted in more patients decreasing their glycated hemoglobin levels by at least 1%.
A piece by benefitnews.com cited an article published on AJMC.com, the website of AJMC®. The article, “Racial Disparities Persist in Maternal Morbidity, Mortality and Infant Health,” indicated that American women die in childbirth at a higher rate than in any other developed country, with non-Hispanic Black women found to be more than 3 times more likely to have a maternal death than White women in the United States. The article was also spotlighted by WDAM 7.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Use of AI Lets Health System Find Lung Cancer at Early Stages
March 8th 2025Artificial intelligence (AI) helps a Sarasota, Florida, health system catch lung nodules that appear on CT scans for patients treated for scores of conditions, allowing them to be referred for a possible lung cancer diagnosis.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
